Biotech Sector Faces Workforce Cuts Amid FDA Approvals
Biotech firms restructure with layoffs as FDA approves new drugs, exemplifying industry challenges and opportunities.
- Latest
- Trending
Biotech firms restructure with layoffs as FDA approves new drugs, exemplifying industry challenges and opportunities.
Explore top biotech ETFs like XBI, BBH, and IBB, offering potential returns and portfolio diversification in a growing market.
Catch up on biotech headlines: Zentalis faces FDA hold, Aerovate's major setback, Merck's new vaccine, and promising trials by Intra-Cellular ...
Catch up on biotech headlines: Zentalis faces FDA hold, Aerovate's major setback, Merck's new vaccine, and promising trials by Intra-Cellular ...
"Discover 7 breakthrough biotech stocks poised to boost your portfolio in a sector projected to reach $521.6B by 2033. Learn ...
This article provides predictions for annual dividend increases for several long-term dividend growth companies, including Coca-Cola and UPS.
Investors are advised on tomorrow's top stock picks as NVIDIA and Lam Research thrive, while Intel and Gilead Sciences face ...
U.S. stocks inch up as Wall Street reflects on a historic week, with the S&P 500 and Nasdaq Composite reaching ...
Gilead Sciences plans to acquire CymaBay Therapeutics for $4.3 billion, expanding their liver disease portfolio. The deal is expected to ...
Gilead Sciences acquires CymaBay Therapeutics for $4.3 billion to expand its liver disease portfolio, including access to potential treatment for ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.